Location History:
- Solebury, PA (US) (1998)
- Gwynedd Valley, PA (US) (1999 - 2000)
Company Filing History:
Years Active: 1998-2000
Title: Michelle A Sparks: Innovator in Oxytocin Receptor Antagonists
Introduction
Michelle A Sparks is a prominent inventor based in Gwynedd Valley, PA (US). She has made significant contributions to the field of pharmacology, particularly in the development of oxytocin receptor antagonists. With a total of 3 patents to her name, her work has the potential to impact the treatment of preterm labor and related conditions.
Latest Patents
One of her latest inventions is focused on tocolytic oxytocin receptor antagonists. This invention relates to novel benzoxazinone compounds and their derivatives, which are synthesized for use as oxytocin receptor antagonists. These compounds are particularly useful in treating preterm labor in mammals, especially humans. Additionally, they can help relax uterine contractions, making them beneficial for treating dysmenorrhea and stopping labor prior to cesarean delivery.
Another significant patent by Sparks involves piperazine oxytocin receptor antagonists. Similar to her previous work, this invention pertains to novel piperazine compounds and their derivatives. These compounds also serve as oxytocin receptor antagonists and have applications in the treatment of preterm labor and related conditions.
Career Highlights
Michelle A Sparks is currently associated with Merck & Company, Inc., where she continues to innovate and contribute to the field of medicine. Her work is characterized by a strong focus on developing solutions that address critical health issues.
Collaborations
Throughout her career, Sparks has collaborated with notable colleagues, including Peter D Williams and Roger M Freidinger. These collaborations have likely enhanced her research and development efforts, leading to impactful innovations.
Conclusion
Michelle A Sparks is a trailblazer in the field of pharmacology, with her inventions paving the way for advancements in the treatment of preterm labor and related conditions. Her contributions are invaluable to the medical community and highlight the importance of innovation in healthcare.